Global ovarian cancer rates 'set to rise significantly'

The number of women being diagnosed with ovarian cancer is likely to see a significant increase over the next two decades, according to a new study.

The World Ovarian Cancer Coalition, a group of patient organisations, has published its 2018 Every Woman Study, which has collated data from 1,000 women in 39 countries, making it the most comprehensive study ever of the global impact of ovarian cancer.

It predicted that ovarian cancer incidence will rise by nearly 55 per cent in the next 20 years unless urgent action is taken, with UK incidence rates projected to increase by 15 per cent over this period.

Ovarian cancer continues to have the lowest survival prospects of all female cancers, with five-year survival rates ranging between 30 per cent and 50 per cent. By comparison, more than 80 per cent of women with breast cancer will survive for five years or more in many countries.

Elisabeth Baugh, chair of the World Ovarian Cancer Coalition, said: "This study tells us that unfortunately ovarian cancer continues to lag far behind the many other cancers that have made good progress in recent years, like breast cancer."ADNFCR-2094-ID-801846537-ADNFCR